STAT3 inhibition induces immunogenic cell death (ICD) of HCC cells via translocation of the “eat me” molecule calreticulin to the cell surface and a significant reduction in exposure of the “don’t eat me” molecule CD47. The gene discussed is CALR; the disease is hepatocellular carcinoma.